100 mg ghk cu COPPER 100mg – My Store GHK-Cu – NovaVitality

FDA currently lists BPC-157 among compounding substances for which it has identified potential immunogenicity, peptide-impurity, and API-characterization concerns, while noting that it has limited safety information for proposed routes of administration

It can lead to incorrect dosing, which completely skews your data

Because human safety data are still limited and BPC-157 is not FDA-approved, patient selection matters

This article walks through what the research actually says in 2026 what each peptide does, how it interacts with PMOS biology, what outcomes have been measured, and what is still unknown

FASEB Journal, 25(3), 907915